Cellyan Biotechnology Co., Ltd carries a market capitalization of 3.94M, placing it among publicly traded companies globally.
| Market Cap | 3.94M |
| Enterprise Value | N/A |
Cellyan Biotechnology Co., Ltd's stock has declined approximately -73.64706% over the past 52 weeks. The 50-day moving average sits at 0.47, while the 200-day moving average is 0.76.
| Beta (5Y) | N/A |
| 52-Week Price Change | -73.64706% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 0.76 |
| Average Volume (20 Days) | N/A |